Fast start for coronavirus drug boosts Gilead earnings, sends stock higher in late trading
October 28, 2020 at 15:14 PM EDT
In the first quarter of sales of its COVID-19 antiviral drug, Gilead Sciences Inc. produced better profit and sales than expected, sending its beleaguered shares higher in late trading.